Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Pharmacogenomics J. 2018 Sep 20;19(3):295–304. doi: 10.1038/s41397-018-0049-x

Fig. 1.

Fig. 1

Adjusted odds ratios and 95% CIs for resistant hypertension risk for MSX2 rs11749255 in INternational VErapamil-SR Trandolapril STudy (INVEST) Whites, INVEST Hispanics, Secondary Prevention of Small Subcortical Strokes (SPS3) Whites, SPS3 Hispanics, and meta-analysis